Entrada Therapeutics, Inc.
TRDA
Revenue
94.69M
▲35.57M▲60.17%
3 Months ChangeAssets
581.96M
▲71.12M▲13.92%
3 Months ChangeLiabilities
152.04M
▼-89.44M▼-37.04%
3 Months ChangeFree Cash Flow
-26.36M
▼-228.09M▼-113.07%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-13
Form 10-Q
ID: 0001689375-24-000047
2024-08-13
Form 8-K
ID: 0001689375-24-000045
2024-06-24
Form 8-K
ID: 0001104659-24-074130
2024-06-24
Form 8-K
ID: 0001104659-24-074078
2024-06-13
Form 8-K
ID: 0001104659-24-071249
2024-05-07
Form 10-Q
ID: 0001689375-24-000027
2024-05-07
Form 8-K
ID: 0001689375-24-000025
2024-03-13
Form 8-K
ID: 0001689375-24-000014
2024-01-03
Form 8-K
ID: 0001104659-24-000571
2023-12-06
Form 8-K
ID: 0001104659-23-123805